Schrödinger to report Q2 2026 earnings August 5
The company will host a conference call at 4:30 p.m. ET after markets close.
See the latest news and media coverage for Schrödinger. We track all announcements, press releases, and industry mentions in real time, all in one place.
Physics-based software platform for molecular discovery and design
schrodinger.comLast updated
In short: Schrödinger expanded its AI and physics-based drug discovery platform through major partnerships with NVIDIA, Lilly, and Simcere.
The company will host a conference call at 4:30 p.m. ET after markets close.
Inducement grants include a stock option for 1,875 shares and RSUs for 18,766 shares, vesting over four years.
The company also announced plans to launch Bunsen, an agentic AI co-scientist, this summer.
The company granted stock options and RSUs to three new employees as employment inducement.
Relay is a reminder that computational-discovery platforms are increasingly judged by clinical...
Detailed price information for Schrodinger Inc (SDGR-Q) from The Globe and Mail including charting and trades.
Schrödinger, Inc. (NASDAQ:SDGR) is among the Best Pharmaceutical Stocks. On May 14, Morgan Stanley lowered its price target on Schrödinger, Inc. (NASDAQ:SDGR) to $17 from...
In May 2026, Schrödinger, Inc. reaffirmed its second-quarter and full-year 2026 financial and operational guidance and announced that Mannix Aklian had stepped down as Chief...
Track Schrödinger and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Schrödinger and other trending companies.